Our Product Pipeline
Stem Cell Therapies
Peptide Therapeutics
Vaccines
Stem Cell Therapies: Regenerative Medicine
Our stem cell pipeline focuses on regenerative medicine and advanced cell therapies to address chronic and life-threatening diseases prevalent in Africa, leveraging our state-of-the-art facility in Uganda. We are pioneering the use of clinical-grade Mesenchymal Stem Cells (MSCs) and establishing Africa’s first cord blood bank.
- Developing MSCs for tissue repair and anti-inflammatory applications.
- Establishing Africa’s first cord blood bank.
- Targeting Sickle Cell Disease, Diabetes, and Neurological Disorders.
Peptide Therapeutics: Precision Drug Delivery
Peptide therapeutics represent a rapidly growing class of drugs with high specificity and low toxicity. Our focus is on developing novel peptides for chronic disease management and anti-infective applications, offering a safer alternative to traditional small molecules.
- Researching peptides to combat drug-resistant bacteria and viruses.
- Developing peptide analogues for metabolic disorders (Type 2 Diabetes).
- Exploring non-opioid peptide-based solutions for chronic pain relief.
Vaccines: Local Production, Global Standards
Leveraging our advanced biomanufacturing facility, our vaccine pipeline is focused on producing essential and next-generation vaccines to combat high-burden infectious diseases in the region. We are committed to using cutting-edge platforms like mRNA and viral vectors.
- Utilizing mRNA platforms for rapid development against emerging pathogens.
- Developing viral vector-based vaccines for diseases like Ebola and Lassa Fever.
- Local production of high-demand vaccines (MMR, Hepatitis B, HPV).
